Reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma or ocular hypertension. − As monotherapy in patients in whom topical beta-blocker therapy is contraindicated. − As adjunctive therapy to other intraocular pressure lowering medications when the target IOP is not achieved with a single agent (see section 5.1).
Retinal Diseases Retinal diseases take many forms, including age-related macular degeneration, diabetic macular oedema, retinal vein occlusions and uveitis, and...
Medtronic, Inc. has announced the FDA approval of its newest cardiac resynchronization therapy-pacemaker, Viva CRT-P, for indicated patients with Heart...